Jefferies analyst Roger Song confirmed a Buy rating and a price target of $8.00 for IO Biotech (NASDAQ:IOBT) shares. The ...
Hosted on MSN32m
Exelixis Stock Falls as Oppenheimer Downgrades Rating to PerformShares of Exelixis EXEL were down 5.13% on Jan. 24, following a downgrade in rating by analysts at Oppenheimer. Oppenheimer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback